Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16

Steve Whetton, Robert Tait, Agata Chrzanowska, Neil Donnelly, Alice McEntee, Aqif Mukhtar, Emma Zahra, Gabrielle Campbell, Louisa Degenhardt, Tania Dey, Suraya Abdul Halim, Wayne Hall, Marshall Makate, Richard Norman, Amy Peacock, Ann Roche, Steve Allsop

    Research output: Book/ReportCommissioned report

    Abstract

    In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years) (Chrzanowska et al., 2019). The extra-medical use of opioids is also likely to result in other adverse outcomes including those that: require the use of health services; reduce work productivity; or, result in contact with the criminal justice system.
    Original languageEnglish
    Place of PublicationPerth, Western Australia
    PublisherNational Drug Research Institute
    Number of pages198
    ISBN (Print)978-0-6487367-0-7
    Publication statusPublished - Feb 2020

    Keywords

    • Pharmaceutical misuse
    • opioid misuse
    • illicit drug use
    • social costs

    Fingerprint Dive into the research topics of 'Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16'. Together they form a unique fingerprint.

    Cite this